<DOC>
	<DOCNO>NCT01021410</DOCNO>
	<brief_summary>The purpose study well understand pharmacokinetics acetaminophen clinical interpretation laboratory result confirm presence acetaminophen-cys adduct . This study determine long adduct persist serum therapeutic course acetaminophen take previous study ( COMIRB 06-1265 ) . Subjects ask complete three study visit , three day apart , follow termination COMIRB 06-1265 . Each study visit include collection blood sample batch test aminotransferase , serum acetaminophen protein adduct . No intervention plan .</brief_summary>
	<brief_title>Acetaminophen-Protein Adduct Resolution</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Any subject randomize acetaminophen arm COMIRB 061265 meet completion criterion Subjects enter extend dosing period protocol 061265 . Subjects randomize placebo .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>acetaminophen</keyword>
	<keyword>paracetamol</keyword>
	<keyword>protein adduct</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>acetaminophen-protein adduct formation</keyword>
</DOC>